We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Cable Software Limited (“Cable Software” or the “Company”) aspires to become the recognised B2B cloud based procurement exchange across the high-end regulated medi-markets. Initially, the Company is focusing upon the dental market before moving into veterinary, ophthalmic and general medicine. Helping dentists to work closely together.
days to go: Expired investment: £10,000
ALVÁTECH is a sustainable water technology company on a mission to revolutionise the $1.3 trillion per annum agriculture industry that consists of 537 million farmers. It claims that the agriculture industry uses 70% of global water consumption. ALVÁTECH aspires to change this. It argues that its technology disrupts water molecules in an ecological way, helping farmers grow more with less water. The plug and play solution runs entirely off solar energy and is chemical-free. ALVÁTECH claims that it has installed its water treatment devices in 17 countries across six continents and established an international distribution network since its product launch in August 2020. The company has also signed agreements with entities in Latin America, Africa, Asia, the US, Europe and the Middle East. ALVÁTECH will use the investment to expand its distribution network, sales teams and subscription plans to reach more farmers and develop Hydro devices for vertical farming, boost hydroponics, and create ALVÁ personal home devices.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £504,932
Arkivum Limited is a cloud-based Software as a Service (SaaS) that provides specialist digital archiving and preservation services to customers in highly regulated industries, such as pharmaceuticals. Arkivum asserts that its software ensures that the digital content of its customers is safeguarded, usable, and auditable for decades into the future. Arkivum argues that its focus area is archiving clinical trial data for pharmaceutical companies, centring around Electronic Trial Master File (eTMF) that contain tens of thousands of different types of documents and overseen closely by drug sponsors. The company further claims that its services triumph over those offered by Amazon Web Services (AWS), Google Cloud Platform (GCP) and Microsoft Azure. Arkivum points out that its services have led to the company earning £1.4 million as Annual Recurring Revenue (ARR) as of March 2021. Arkivum is seeking to raise up to £1.075 million of equity to grow its business across different verticals.
days to go: Expired investment: Withheld
Arca have introduced new tools for property risk management and created a marketplace to trade portfolio risks to match buyers and sellers of financial products connected to the performance of real estate. They are opening up the concept of short term property market risk management for property portfolio managers.  
days to go: Expired investment: £575,000
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go: Expired investment: Withheld
Elute Intelligence is an online platform that makes searching documents fast, simple, and accurate. The platform is optimised to handle a variety of tasks such as plagiarism detection, patent searching, fraud detection, governance and compliance, and e-discovery to name a few. Using a unique AI-based system, users can upload long-form documentation, and the system will analyse, tag, and find related articles across a wide range of academic journals and data sources. The company is looking to engage in partnerships: with government and commercial R&D teams to help accelerate research into Covid-19, with development partners to help expand the system into other research areas, and with investors interested in an AI and big data platform that can transform scientific research processes.

Pitch Rated

40%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Bodytrak is a wearable technology that monitors physiological activity such as heart rate and core body temperature.  This real time data is analysed using cloud based technology and algorithms to supervisors or commanders so early action can be taken on the event of illness or injury.
days to go: Expired investment: £1,123,119
Five Points Brewing Company are an independent craft brewery.  Since the company started in 2013, the demand has risen beyond capacity and they are looking for investment to treble the capacity of their brewery and open a Tap Room on the five point’s junction they are named after.
days to go: Expired investment: £1,141,840
Invluencer is a Venture Capital (VC) company with an economic model designed to bring VC to the masses. Invluencer believes in boosting greater investment capability between investors and company representatives. This is undertaken by creating a smart-contract enabled 'Intelligent Wallet' for autonomous investment in vetted high-growth companies facilitated by Invluencer’s unique Multi-Asset Platform (I-MAP) and Intelligent Distributed Due Diligence (i3D) platform. Through these platforms, the company aims to simplify investment and open liquidity between worthy companies and accredited investors. The company will use the investments to continue the development of due diligence and fund management platforms, strengthen the investment team and analysis team, strengthen relationships and partnerships within the VC ecosystem.

Pitch Rated

43%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £154,000
Troubadour is a London-based menswear brand specialising in designing minimalist bags & accessories by combining performance design with a clean & modern aesthetic feel. The company has delivered its products to 60+ wholesalers. It is backed by Pembroke VCT, a luxury-focused venture capital firm based in London. Troubadour is planning to work with non-traditional retailers including Ritz Carlton, Four Seasons, and Equinox. It has also collaborated with many world-renowned brands such as British tailors 'Thom Sweeney' and British essentials brand 'Sunspel' that is famous for clothing James Bond. The company has also been a case study for classes at the Harvard Business School. With the investment, the company will support sales growth to its customers and retail partners and also fund working capital requirements from its forecast growth plan.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £621,240
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph